🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/09/2008 | 13,51 | 13,51 | 12,43 | 12,58 | -7,69% | 8,03% | 50.307 |
| 19/09/2008 | 12,88 | 13,62 | 11,64 | 13,62 | +10,30% | 15,41% | 476.144 |
| 18/09/2008 | 11,98 | 12,91 | 11,04 | 12,35 | +5,77% | 15,63% | 297.276 |
| 17/09/2008 | 11,87 | 13,59 | 11,68 | 11,68 | -12,36% | 16,09% | 971.739 |
| 16/09/2008 | 11,34 | 13,33 | 11,27 | 13,33 | +13,74% | 18,15% | 800.725 |
| 15/09/2008 | 12,28 | 12,73 | 11,68 | 11,72 | -6,85% | 8,54% | 72.723 |
| 12/09/2008 | 12,61 | 12,69 | 12,13 | 12,58 | -0,89% | 4,45% | 37.296 |
| 11/09/2008 | 12,65 | 12,80 | 11,72 | 12,69 | +0,59% | 8,58% | 153.835 |
| 10/09/2008 | 12,99 | 13,18 | 12,46 | 12,61 | +0,30% | 5,48% | 110.313 |
| 09/09/2008 | 13,40 | 13,59 | 12,50 | 12,58 | -5,62% | 8,10% | 79.829 |
| 08/09/2008 | 12,50 | 13,62 | 11,68 | 13,33 | +10,90% | 15,57% | 105.558 |
| 05/09/2008 | 12,43 | 13,03 | 11,72 | 12,02 | -3,31% | 10,54% | 107.588 |
| 04/09/2008 | 12,35 | 13,10 | 12,05 | 12,43 | -0,60% | 8,48% | 138.526 |
| 03/09/2008 | 12,16 | 12,76 | 12,16 | 12,50 | +2,77% | 4,92% | 61.101 |
| 02/09/2008 | 12,84 | 12,99 | 12,02 | 12,16 | -3,85% | 7,58% | 26.209 |
| 29/08/2008 | 12,73 | 12,73 | 12,35 | 12,65 | -0,59% | 2,94% | 42.105 |
| 28/08/2008 | 11,68 | 12,76 | 11,42 | 12,73 | +8,97% | 11,54% | 70.265 |
| 27/08/2008 | 11,94 | 11,94 | 11,45 | 11,68 | -2,50% | 4,08% | 298.185 |
| 26/08/2008 | 11,79 | 12,43 | 11,75 | 11,98 | +1,91% | 5,71% | 27.117 |
| 25/08/2008 | 12,28 | 12,50 | 11,64 | 11,75 | -4,27% | 7,01% | 28.480 |
| 22/08/2008 | 11,57 | 12,39 | 11,34 | 12,28 | +7,19% | 9,06% | 50.735 |
| 21/08/2008 | 11,87 | 12,50 | 11,42 | 11,45 | -4,08% | 9,15% | 75.341 |
| 20/08/2008 | 12,43 | 12,58 | 11,60 | 11,94 | -3,63% | 7,83% | 46.006 |
| 19/08/2008 | 12,43 | 12,88 | 11,90 | 12,39 | -2,07% | 7,83% | 47.342 |
| 18/08/2008 | 12,88 | 13,03 | 12,50 | 12,65 | -1,74% | 4,07% | 46.514 |
| 15/08/2008 | 13,21 | 13,66 | 12,73 | 12,88 | -1,71% | 7,08% | 100.909 |
| 14/08/2008 | 12,95 | 13,29 | 12,95 | 13,10 | +0,29% | 2,60% | 85.520 |
| 13/08/2008 | 13,06 | 13,59 | 12,99 | 13,06 | -0,29% | 4,58% | 93.829 |
| 12/08/2008 | 13,06 | 13,14 | 12,16 | 13,10 | +0,00% | 7,45% | 1.132.012 |
| 11/08/2008 | 12,95 | 13,70 | 12,80 | 13,10 | +1,45% | 6,94% | 84.745 |